Undetectable Thyroglobulin Levels in Poorly Differentiated Thyroid Carcinoma Patients Free of Macroscopic Disease After Initial Treatment: Are They Useful?

[1]  J. Shah,et al.  Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer--is there a need for radioactive iodine therapy? , 2012, Surgery.

[2]  T. Fahey.  The value of detectable thyroglobulin in patients with differentiated thyroid cancer after initial 131I therapy , 2012 .

[3]  M. Papotti,et al.  Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression , 2010, Modern Pathology.

[4]  Stephanie L. Lee,et al.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[5]  M. Hirokawa,et al.  Classification of follicular cell tumors of the thyroid gland: Analysis involving Japanese patients from one institute , 2009, Pathology international.

[6]  M. Hirokawa,et al.  [Poorly differentiated carcinoma of the thyroid]. , 2007, Nihon rinsho. Japanese journal of clinical medicine.

[7]  S. Larson,et al.  Radioactive iodine therapy in poorly differentiated thyroid cancer , 2007, Nature Clinical Practice Oncology.

[8]  J. Brierley,et al.  An evidence-based review of poorly differentiated thyroid cancer , 2007, World Journal of Surgery.

[9]  Tae Yong Kim,et al.  Clinical features and prognostic factors for survival in patients with poorly differentiated thyroid carcinoma and comparison to the patients with the aggressive variants of papillary thyroid carcinoma. , 2007, Endocrine journal.

[10]  J. Shah,et al.  Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis , 2006, Cancer.

[11]  N. Theodore,et al.  Report of two cases and review of the literature , 2006 .

[12]  S. Larson,et al.  Factors influencing the basal and recombinant human thyrotropin-stimulated serum thyroglobulin in patients with metastatic thyroid carcinoma. , 2004, The Journal of clinical endocrinology and metabolism.

[13]  M. Papotti,et al.  Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns , 2004, Cancer.

[14]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[15]  J. Shah,et al.  Intermediate-risk group for differentiated carcinoma of thyroid. , 1994, Surgery.

[16]  D. Schuller,et al.  Poorly differentiated ('insular') thyroid carcinoma. Report of two cases and review of the literature. , 1990, Archives of otolaryngology--head & neck surgery.

[17]  L. Woolner,et al.  Undifferentiated and poorly differentiated carcinoma. , 1985, Seminars in diagnostic pathology.

[18]  A. Sakamoto,et al.  Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high‐risk group of papillary and follicular carcinomas , 1983, Cancer.